This week we come to meta-analyse, strikingly late, the cornerstone of all CKD treatments. Are you still in doubt? We need ACEing CKD to the end of GFR, and beyond
This week, we will discuss hopefully the final story of intensive BP lowering. BPROAD is a larger version of ACCORD without the glycemic control arm. Dive in.
Its that time of year again! Jade Teakell is leading team #UrineItToWinIt for #HCWvsHunger 2024. Read more.
This week, we will discuss the use of 3K dialysis bath with sodium zirconium cyclosilicate versus 2K bath and no potassium lowering medications in dialysis patients and the associated risk of arrhythmia.
Sinead Stoneman, recent NSMC graduate produced these two visual abstracts for this week’s #NephJC chat.
Some additional visual enjoyment related to the Humphreys study
Still wish @CellStemCell had chosen our cover art submission! Designed by @BuryLeah with inspiration from @Kohei_Uchimura #organoids #PikePseudotime pic.twitter.com/S2yb0qGjMW
— Ben Humphreys (@HumphreysLab) November 26, 2018
82k scTranscriptomes later excited to annouce that our kidney #organoid MS is now out in @CellStemCell ! A true team effort: @morris_lab @HaojiaWu @Kohei_Uchimura @ykirita @WUSTLmed @cziscience @humancellatlas https://t.co/LRyQxUip3D pic.twitter.com/7lHgNlBVkz
— Ben Humphreys (@HumphreysLab) November 15, 2018
